Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients

Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, Vetter M, Weigmann B, Turowska A, Muhl T, Homburg U, Renz J, Vieth M, Garn H, Renz H, Neurath M (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Journal of Crohns & Colitis Elsevier

Book Volume: 12

Pages Range: S69-S70

DOI: 10.1093/ecco-jcc/jjx180.092

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur) Maximilian Waldner Lehrstuhl für Innere Medizin I Sven Moritz Fischer Department of Paediatrics and Adolescent Medicine Marcel Vetter Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Benno Weigmann Medizinische Fakultät Markus Neurath Lehrstuhl für Innere Medizin I

Involved external institutions

Asklepios Kliniken DE Germany (DE) sterna biologicals GmbH & Co KG DE Germany (DE) Philipps-Universität Marburg DE Germany (DE)

How to cite

APA:

Atreya, R., Kuehbacher, T., Schmitt, H., Hirschmann, S., Waldner, M., Drvarov, O.,... Neurath, M. (2018). Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients. (pp. S69-S70).

MLA:

Atreya, Raja, et al. "Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients." 2018. S69-S70.

BibTeX: Download